Eclampsia: all 328 studies

Page 2 of 4. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis AssaysStatus unknownNCT05625763
• Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic WomenStatus unknownNCT05622838
• The Effect of Magnesium Use in Reversal of Neuromuscular Block With SugammadexCompletedNCT05558969Not applicable
• Probiotic Supplementation During Pregnancy in Preeclampsia High-risk GroupsStatus unknownNCT05554185Not applicable
• The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With HypertensionCompletedNCT05542654Not applicable
• Body Fat Index for Obstetric Risk StratificationStatus unknownNCT05533996Not applicable
• Blood Pressure Monitoring in Postpartum Women at Risk of HypertensionStatus unknownNCT05457504Not applicable
• Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm BirthStatus unknownNCT05436119
• Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsiaCompletedNCT05310929Not applicable
• Telocytes in Umbilical Cord of Patients With and Without Pre-eclampsiaStatus unknownNCT05305339
• Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff MeasurementsCompletedNCT05299229
• Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe PreeclampsiaCompletedNCT05283473
• Improved Characterisation of EclampsiaStatus unknownNCT05199558
• Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic PatientsStatus unknownNCT05176652
• Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe FeaturesStatus unknownNCT05152550
• The Clinical and Prognostic Features of PRESCompletedNCT05143710
• Understanding Post-translational Modifications to Circulating Histones Via Mass Spectrometry in Pregnant Women Developing Pre-eclampsia: A Retrospective StudyCompletedNCT05142410
• Maternal Serum Markers Predicting Preeclampsia At Early GestationsCompletedNCT05131282
• Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)Status unknownNCT05123677
• Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in PregnancyCompletedNCT05121415
• Dexamedtomidine in Control of Intracranial Pressure in PreeclampsiaStatus unknownNCT05119101Phase 1
• Early Onset Preeclampsia and Nectin-4CompletedNCT05098691
• Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)CompletedNCT05096728
• Cardiovascular Risk in Infants Exposed to Pre-eclampsia in UteroStatus unknownNCT05091827
• Virtual Cardiac Wellness Program Following Hypertensive Disorders of PregnancyActive, not recruitingNCT04998942Not applicable
• Role of L-citrulline in Prevention of Pregnancy Associated HypertensionTerminatedNCT04979793Phase 1
• Concordance Between the Systolic Foot-to-Apex Interval and the Auscultatory Method for Measuring Brachial Systolic Pressure in Pregnant Women With or Without Blood Pressure Disorders and Search for Markers of Arterial Stiffness in Pre-eclampsia.CompletedNCT04943133Not applicable
• Aspirin for the Prevention of Preeclampsia in Women With Stage 1 HypertensionStatus unknownNCT04908982Phase 4
• Placental Volume, Flow, and Vascularity StudyCompletedNCT04900207
• sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) StudyStatus unknownNCT04877119
• Prevention of Pre-eclampsia Using Metformin: a Randomized Control TrialStatus unknownNCT04855513Not applicable
• Management of Hypertension in the Early Postpartum: a Randomized Controlled TrialCompletedNCT04835233Phase 4
• Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease MarkersStatus unknownNCT04833881
• Prenatal Yoga as Complementary Therapy of PreeclampsiaCompletedNCT04795154Not applicable
• Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of PregnancyStatus unknownNCT04767438
• Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive DisordersTerminatedNCT04713228Not applicable
• Cardiovascular Changes in Infants of Preeclampsia MotherStatus unknownNCT04699825Not applicable
• Comparative Study for the Validity of Various Severity Scoring SystemCompletedNCT04683094
• Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia.CompletedNCT04658966
• The Effectiveness of Aspirin on Preventing Pre-eclampsiaStatus unknownNCT04656665Phase 4
• The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in PregnancyStatus unknownNCT04604535Not applicable
• Breastfeeding and Postpartum Cardiovascular HealthActive, not recruitingNCT04580927Not applicable
• Natural Versus Programmed Frozen Embryo Transfer (NatPro)Active, not recruitingNCT04551807Phase 3
• Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal PathwayStatus unknownNCT04514276Not applicable
• Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/EclampsiaCompletedNCT04501289Not applicable
• Preeclampsia Associated Vascular AgingStatus unknownNCT04484766
• Xanthine Oxidase and Uric Acid Origin in Preeclamptic WomenStatus unknownNCT04463940
• Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in PreeclampsiaCompletedNCT04455204
• Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36Status unknownNCT04424693Phase 4
• Precision Medicine for Prediction & Prevention of Early Pre-eclampsiaStatus unknownNCT04412681Not applicable
• MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivoCompletedNCT04389099
• Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic WomenCompletedNCT04374604
• Optic Nerve Sheath Diameter for Volume Status Prediction in Severe PreeclampsiaCompletedNCT04367519
• Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?CompletedNCT04363021
• Vitamin D in PregnancyStatus unknownNCT04291313Not applicable
• Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in PreeclampsiaStatus unknownNCT04287998
• Physician Optimised Post-partum Hypertension Treatment TrialActive, not recruitingNCT04273854Not applicable
• Preeclamptic Patients and Pentraxin 3 & Lipoprotein-associated Phospholipase A2CompletedNCT04239352
• Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for PreeclampsiaCompletedNCT04204018Not applicable
• Interest of sFlt1/PlGF Ratio at Obstetric EmergenciesActive, not recruitingNCT04170660
• Incidence and Neonatal Outcome of Eclamptic Parturient in Tertiary Hospital.CompletedNCT04160923
• Comparison of Longitudinal Blood Pressure and Arterial Stiffness in Preeclamptic Women After DeliveryCompletedNCT04142268
• Maternal and Neonatal Outcome in Severe PreeclampsiaStatus unknownNCT04126122
• Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo TransferTerminatedNCT04092829Not applicable
• qMOLI- A Qualitative Assessment of Misoprostol or Oxytocin for Labour InductionCompletedNCT04037683
• Optic Nerve Sheath Diameter in PreeclampsiaCompletedNCT04004897Not applicable
• Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')CompletedNCT03993145Not applicable
• An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in TanzaniaCompletedNCT03978429Not applicable
• SMARThealth Pregnancy: Feasibility & Acceptability of a Complex Intervention for High-risk Pregnant Women in Rural India.CompletedNCT03968952Not applicable
• The CoPenHagen PREeClampsia and cardIOvascUlar diSease StudyActive, not recruitingNCT03949829
• Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)CompletedNCT03941886Not applicable
• Impact of Body Mass Index on Serum Maternal and Fetal Magnesium LevelStatus unknownNCT03928691
• Electroencephalographic Effects of Spinal Anaesthesia During Caesarean Delivery in PreeclampsiaStatus unknownNCT03917342Not applicable
• Vitamin D Level and Its Relation to Pre-eclampsia and EclampsiaStatus unknownNCT03882099
• Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsiaTerminatedNCT03863639
• Optimizing Gestational Weight Gain, Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in PregnancyStatus unknownNCT03858595Not applicable
• Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric DiagnosisCompletedNCT03856307
• Comparison Between Uterine Artery Doppler and Placental Vascular Indices in Prediction of PreeclampsiaStatus unknownNCT03838887
• Study for Improving Maternal, Pregnancy and Child OutcomesCompletedNCT03831490
• Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve StratificationCompletedNCT03815110
• Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant WomenStatus unknownNCT03767803
• PREDICTION OF FLUID RESPONSIVENESS WITH PASSIVE LEG RISING IN PREGNANT PATIENTS WITH SEVERE PREECLAMPSIACompletedNCT03755843
• ASA Patterns for Prevention of Preeclampsia in SLE PregnanciesCompletedNCT03749044Not applicable
• Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of PregnancyCompletedNCT03741179Phase 3
• Management of Suspected Preeclampsia Based on 6-hour Versus 24-hour Urine Protein CollectionStatus unknownNCT03724786Not applicable
• Esomeprazole for the Prevention of PreeclampsiaStatus unknownNCT03717740Phase 3
• Metformin and Esomeprazole in Treatment of Early Onset PreeclampsiaStatus unknownNCT03717701Not applicable
• Prediction of Preeclampsia by Comprehensive Markers.CompletedNCT03665623
• Serum Magnesium Level Administration in Severe Pre-eclampsia Obese PregnancyCompletedNCT03661775Not applicable
• C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese PregnanciesCompletedNCT03650790Not applicable
• Indonesia Pravastatin to Prevent Preeclampsia StudyStatus unknownNCT03648970Phase 2
• Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsiaStatus unknownNCT03630276Not applicable
• TTP and aHUS in Complicated PregnanciesStatus unknownNCT03605511
• Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110BCompletedNCT03567551
• microRNAs Role in Pre-eclampsia DiagnosisCompletedNCT03562715
• Prediction of Preeclampsia (PE) at 11-13 WeekCompletedNCT03554681
• Springfusor for Administration of Magnesium Sulphate in Preeclampsia and EclampsiaStatus unknownNCT03549767Not applicable
• Fetal Doppler Indices in Predicting Perinatal Outcome Among Severely Hypertensive Pregnant Patients.CompletedNCT03515759
• Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsiaCompletedNCT03466333Phase 2
• Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.CompletedNCT03455387

← Eclampsia overview